Cargando…
The effect of vitamin D supplementation on the outcome of treatment with bevacizumab in diabetic macular edema: a randomized clinical trial
PURPOSE: Concomitant vitamin D deficiency (VDD) is speculated to aggravate diabetic macular edema (DME). We aimed to determine the effect of hypovitaminosis D correction on the outcome of treatment with intravitreal bevacizumab (IVB) in DME eyes. METHODS: In this randomized clinical trial, 83 eyes o...
Autores principales: | Fekri, Sahba, Soheilian, Masoud, Roozdar, Sepehr, Abtahi, Seyed-Hossein, Nouri, Hosein |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9093557/ https://www.ncbi.nlm.nih.gov/pubmed/35543853 http://dx.doi.org/10.1007/s10792-022-02333-2 |
Ejemplares similares
-
Ziv-aflibercept in Diabetic Macular Edema: Relation of Subfoveal Choroidal Thickness with Visual and Anatomical Outcomes
por: Moradian, Siamak, et al.
Publicado: (2023) -
Effects of Oral Vitamin D Supplement Therapy on Clinical Outcomes of Intravitreal Bevacizumab in Diabetic Macular Edema
por: Karimi, Saeed, et al.
Publicado: (2021) -
Combined intravitreal injection of bevacizumab and a ROCK inhibitor (fasudil) for refractory macular edema secondary to retinal vein occlusion: a pilot study
por: Fekri, Sahba, et al.
Publicado: (2022) -
Intravenous Immunoglobulin for Management of Non-paraneoplastic Autoimmune Retinopathy
por: Fekri, Sahba, et al.
Publicado: (2020) -
Intravitreal Diclofenac for Refractory Uveitic Cystoid Macular Edema
por: Ramezani, Alireza, et al.
Publicado: (2013)